Follow the Transcode Therapeutics, Inc. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Transcode Therapeutics, Inc. has recorded 8 public disclosures. Market capitalisation: €6m. The latest transaction was reported on 2 October 2023 (Acquisition). Among the most active insiders: Dudley Robert Michael. The full history is openly available.
8
Insider Decl.
0
Thresholds
€269,443
8 ops.
Buy Volume
·
0 ops.
Sell Volume
58Σ signal
Buys €269,443· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.